Artiva Biotherapeutics, Inc.
- ARTV
- NASDAQ
- Biotechnology
- NK Cell Therapies
- Immuno-Oncology
$5.85
Today −3.47%Quote Oct 16, 2026, 08:00 PM UTC
−30.69%over the last month
Max drawdown −32.1%From 1-month high −32.1%3 months −36.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$286.0M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$37.50
+541.0% from here
Floor
$5.65
3.4% below price
Where the price sits
4 analysts
Analyst range, low to high
$35.00$40.00
- Price $5.85
- Resistance $6.09
- Consensus $37.50
Analysts' average target sits about 541% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ARTVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
115